The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

ludc web

Lena Eliasson

Principal investigator

ludc web

Somatostatin secretion by Na+-dependent Ca2+-induced Ca2+ release in pancreatic delta cells


  • Elisa Vergari
  • Geoffrey Denwood
  • Albert Salehi
  • Quan Zhang
  • Julie Adam
  • Ahmed Alrifaiy
  • Ingrid Wernstedt Asterholm
  • Anna Benrick
  • Margarita V. Chibalina
  • Lena Eliasson
  • Claudia Guida
  • Thomas G. Hill
  • Alexander Hamilton
  • Reshma Ramracheya
  • Frank Reimann
  • Nils J.G. Rorsman
  • Ioannis Spilliotis
  • Andrei I. Tarasov
  • Jonathan N. Walker
  • Patrik Rorsman
  • Linford J.B. Briant

Summary, in English

Pancreatic islets are complex micro-organs consisting of at least three different cell types: glucagon-secreting alpha, insulin-producing beta and somatostatin-releasing delta cells. Somatostatin is a powerful paracrine inhibitor of insulin and glucagon secretion. In diabetes, increased somatostatinergic signalling leads to defective counter-regulatory glucagon secretion. This increases the risk of severe hypoglycaemia, a dangerous complication of insulin therapy. The regulation of somatostatin secretion involves both intrinsic and paracrine mechanisms but their relative contributions and whether they interact remain unclear. Here we show that dapagliflozin-sensitive glucose- and insulin-dependent sodium uptake stimulates somatostatin secretion by elevating the cytoplasmic Na+ concentration (intracellular [Na+]; [Na+]i) and promoting intracellular Ca2+-induced Ca2+ release. This mechanism also becomes activated when [Na+]i is elevated following the inhibition of the plasmalemmal Na+-K+ pump by reductions of the extracellular K+ concentration emulating those produced by exogenous insulin in vivo. Islets from some donors with type-2 diabetes hypersecrete somatostatin, leading to suppression of glucagon secretion that can be alleviated by a somatostatin receptor antagonist. Our data highlight the role of Na+ as an intracellular second messenger, illustrate the significance of the intra-islet paracrine network and provide a mechanistic framework for pharmacological correction of the hormone secretion defects associated with diabetes that selectively target the delta cells.


  • Diabetes - Islet Patophysiology
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • CRC, Clinical Research Centre
  • Diabetes - Islet Cell Exocytosis
  • Diabetes - Molecular Metabolism

Publishing year







Nature Metabolism





Document type

Journal article (letter)


Springer Nature


  • Endocrinology and Diabetes



Research group

  • Diabetes - Islet Patophysiology
  • Diabetes - Islet Cell Exocytosis
  • Diabetes - Molecular Metabolism


  • ISSN: 2522-5812